Structure of p53 264-272 (HLA-A*0201)
Logo for Cancer
Cancer

p53 264-272 (HLA-A*0201) LLGRNSFEV

Product number: EP05796_1

€105.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart

Description

Single peptide LLGRNSFEV for stimulation of p53 (264-272)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Targeting diseases are cancer, allergies, viral infections and autoimmune disorders.

TechData

Sequence: LLGRNSFEV
Gene: TP53
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Protein: Cellular tumor antigen p53
Species: Human
Allele: HLA-A*02:01
Application: Flow Cytometry
Indication: Cancer
Purity: 95% HPLC-MS